Trending...
- California: Three years after the end of Roe, Governor Newsom, First Partner sound the alarm on Trump's "Big, Beautiful" plan to defund Planned Parenthood - 114
- Ascent Solar Technologies Enters Collaborative Agreement Notice with NASA to Advance Development of Thin-Film PV Power Beaming Capabilities: ASTI
- California awards over $15 million to apprenticeship programs connecting youth to high-paying jobs
XTT Cell Viability Assay Kit is a colorimetric assay for studying cell proliferation and cell cytotoxicity.
MILPITAS, Calif. - Californer -- BioVision's XTT Cell Viability Assay Kit is a colorimetric assay for studying cell proliferation and cell cytotoxicity. The assay is based on the reduction of the XTT tetrazolium salt by NADH, which is produced by the mitochondrial dehydrogenase enzymes of metabolically active cells to generate an orange-colored formazan product in the cell media.
This kit can be used for studying cell proliferation in response to cytokines, nutrients, growth factors and mitogens and also for analyzing the cytotoxic and cytostatic effects of drugs, toxins, antibodies and other exogenous chemicals. In this assay, the XTT working solution is added directly to the cell culture media and is read after an incubation of 0.5-4 hr.
The measured absorbance at 475 nm is proportional to the number of viable cells. There are no steps in the assay involving changing of media or washing or addition of any solubilization reagents. The assay can detect cell numbers as high as 500,000 viable cells and as low as 1000 viable cells in each well. The presence of phenol red and/or serum in the cell growth media does not interfere with the assay. The kit provides a safe, easy-to-use, non-radioactive, high-throughput method for characterizing and screening cell viability and cytotoxicity.
More on The Californer
Figures. (A) Standard Curve of viable HeLa cells (0 to 500,000 cells/well). (B) Standard Curve of viable Jurkat cells (0 to 500,000 cells/well). (C) Cytotoxicity dose-response curve of L929 cells (2 x 104 cells/well) following 48 hr treatment with TNF-α (EC50 = 110.4 pg/ml
calculated by 4-parameter logistic curve fitting).
Storage Conditions -20ºC
USAGE For Research Use Only! Not For Use in Humans.
For more information on this Assay Kit Cat# K2108 https://bit.ly/3EfY2nF
This kit can be used for studying cell proliferation in response to cytokines, nutrients, growth factors and mitogens and also for analyzing the cytotoxic and cytostatic effects of drugs, toxins, antibodies and other exogenous chemicals. In this assay, the XTT working solution is added directly to the cell culture media and is read after an incubation of 0.5-4 hr.
The measured absorbance at 475 nm is proportional to the number of viable cells. There are no steps in the assay involving changing of media or washing or addition of any solubilization reagents. The assay can detect cell numbers as high as 500,000 viable cells and as low as 1000 viable cells in each well. The presence of phenol red and/or serum in the cell growth media does not interfere with the assay. The kit provides a safe, easy-to-use, non-radioactive, high-throughput method for characterizing and screening cell viability and cytotoxicity.
More on The Californer
- California: Department of Defense agrees: it's time for Trump's militarization of Los Angeles to end
- Long Beach: City Launches Internet Service Enrollment Line
- Von Rock Law Founder Deidre Von Rock Named Super Lawyer for 2025
- California: Governor Newsom extends emergency short-term housing protections in Los Angeles
- Von Rock Law Named SFGate's Best Probate and Estate Attorney in 2025
Figures. (A) Standard Curve of viable HeLa cells (0 to 500,000 cells/well). (B) Standard Curve of viable Jurkat cells (0 to 500,000 cells/well). (C) Cytotoxicity dose-response curve of L929 cells (2 x 104 cells/well) following 48 hr treatment with TNF-α (EC50 = 110.4 pg/ml
calculated by 4-parameter logistic curve fitting).
Storage Conditions -20ºC
USAGE For Research Use Only! Not For Use in Humans.
For more information on this Assay Kit Cat# K2108 https://bit.ly/3EfY2nF
Source: BioVision Inc
0 Comments
Latest on The Californer
- Long Beach: LA28 Announces Finalized Sailing Venue Plan for 2028 Olympic Games
- Individual Software Announces New Versions of its Four Typing Programs in 2025
- Britt Michaelian Brings Transformative Art & Wellness to The Ecology Center's Peace Dome
- California: Governor Newsom urges safety this Fourth of July after 600,000 pounds of illegal explosives seized
- AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
- Mental and Emotional Self-Management, Practical Tools for Trauma-Informed Stress Management
- CGI+ Sells Multifamily Development Site in Los Angeles' South Bay to JPI for $40 Million
- MicroStrategy Incorporated (MSTR) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Alten Construction awarded Encinal Junior and Senior High School project
- $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
- Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
- Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts
- Preliminary.online Introduces Short-Term Job-Readiness Courses with Employer-Verified Certifications
- Psychologist-Turned-Hermeticist Releases Modern Guide to the Seven Hermetic Principles
- Winners Announced for Asia Pacific Business Awards 2024-2025
- Hamvay-Lang and Lampone.hu Join Forces with AIMarketingugynokseg.hu to Elevate Hungarian Lifestyle Brands on the Global Stage
- Google AI Quietly Corrects the Record on Republic of Aquitaine's Legal Sovereignty